Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.
about
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.
P2860
Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Complete response in gallbladd ...... receptor gene: a case report.
@ast
Complete response in gallbladd ...... receptor gene: a case report.
@en
type
label
Complete response in gallbladd ...... receptor gene: a case report.
@ast
Complete response in gallbladd ...... receptor gene: a case report.
@en
prefLabel
Complete response in gallbladd ...... receptor gene: a case report.
@ast
Complete response in gallbladd ...... receptor gene: a case report.
@en
P2093
P2860
P356
P1433
P1476
Complete response in gallbladd ...... receptor gene: a case report.
@en
P2093
Edward Strauss
Kabir Mody
Richard C Frank
Robert Lincer
P2860
P2888
P356
10.1186/1471-2407-10-570
P407
P577
2010-10-20T00:00:00Z
P5875
P6179
1030033401